Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0578320230460110675
Molecules and Cells
2023 Volume.46 No. 11 p.675 ~ p.687
Activation of Lysosomal Function Ameliorates Amyloid-¥â-Induced Tight Junction Disruption in the Retinal Pigment Epithelium
Jo Dong-Hyun

Lee Su-Hyun
Jeon Min-Sol
Cho Chang-Sik
Kim Da-Eun
Kim Hyun-Kyung
Kim Jeong-Hun
Abstract
Accumulation of pathogenic amyloid-¥â disrupts the tight junction of retinal pigment epithelium (RPE), one of its senescence-like structural alterations. In the clearance of amyloid-¥â, the autophagy-lysosome pathway plays the crucial role. In this context, mammalian target of rapamycin (mTOR) inhibits the process of autophagy and lysosomal degradation, acting as a potential therapeutic target for age-associated disorders. However, efficacy of targeting mTOR to treat age-related macular degeneration remains largely elusive. Here, we validated the therapeutic efficacy of the mTOR inhibitors, Torin and PP242, in clearing amyloid-¥â by inducing the autophagy-lysosome pathway in a mouse model with pathogenic amyloid-¥â with tight junction disruption of RPE, which is evident in dry age-related macular degeneration. High concentration of amyloid-¥â oligomers induced autophagy-lysosome pathway impairment accompanied by the accumulation of p62 and decreased lysosomal activity in RPE cells. However, Torin and PP242 treatment restored the lysosomal activity via activation of LAMP2 and facilitated the clearance of amyloid-¥â in vitro and in vivo. Furthermore, clearance of amyloid-¥â by Torin and PP242 ameliorated the tight junction disruption of RPE in vivo. Overall, our findings suggest mTOR inhibition as a new therapeutic strategy for the restoration of tight junctions in age-related macular degeneration.
KEYWORD
age-related macular degeneration, amyloid-¥â, autophagy-lysosome pathway, LAMP2, PP242, Torin
FullTexts / Linksout information
Listed journal information